| Product Code: ETC320741 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The corticosteroid market in Qatar is witnessing a steady growth trajectory, primarily driven by the increasing prevalence of inflammatory and autoimmune disorders. Corticosteroids are widely prescribed for their potent anti-inflammatory and immunosuppressive properties. The market is benefiting from a growing aging population and rising awareness about the efficacy of corticosteroids in managing various medical conditions. Additionally, advancements in drug delivery systems and formulations are expanding the scope of corticosteroid applications. The presence of both multinational pharmaceutical companies and local manufacturers contributes to the competitive dynamics of the corticosteroid market in Qatar.
The corticosteroid market in Qatar is witnessing growth due to the rising incidence of skin disorders and inflammatory conditions. Corticosteroids are widely prescribed for their anti-inflammatory properties. Factors like increasing healthcare access and awareness of skin health contribute to the market`s positive outlook.
The corticosteroid market in Qatar presents several challenges. One of the major concerns is the potential side effects and health risks associated with prolonged corticosteroid use, which could lead to stricter regulations and reduced demand. Additionally, the need for affordable healthcare and insurance coverage could impact access to corticosteroid treatments, affecting market dynamics.
The Qatar corticosteroid market experienced fluctuations during the COVID-19 pandemic as healthcare resources were redirected towards managing the pandemic. This affected the production and distribution of corticosteroid medications. However, corticosteroids gained attention as a potential treatment for severe COVID-19 cases, leading to increased demand. As the healthcare system stabilizes and focuses on addressing other medical needs, the corticosteroid market is expected to return to a more predictable trajectory.
The Qatar corticosteroid market is expected to experience substantial growth due to the rising prevalence of inflammatory and autoimmune diseases. Corticosteroids are commonly used in the treatment of various medical conditions. Key players in this market include Hamad Medical Corporation, Qatar Pharma, and Gulf Pharmaceutical Industries (Julphar). These companies are at the forefront of pharmaceutical research and development in the country.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Qatar Corticosteroid Market Overview |
3.1 Qatar Country Macro Economic Indicators |
3.2 Qatar Corticosteroid Market Revenues & Volume, 2021 & 2031F |
3.3 Qatar Corticosteroid Market - Industry Life Cycle |
3.4 Qatar Corticosteroid Market - Porter's Five Forces |
3.5 Qatar Corticosteroid Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Qatar Corticosteroid Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Qatar Corticosteroid Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Qatar Corticosteroid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Qatar |
4.2.2 Growing awareness about the benefits of corticosteroids in managing various inflammatory conditions |
4.2.3 Rising healthcare infrastructure and expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines governing the use of corticosteroids |
4.3.2 Side effects associated with long-term corticosteroid use |
4.3.3 Competition from alternative treatment options such as biologics |
5 Qatar Corticosteroid Market Trends |
6 Qatar Corticosteroid Market, By Types |
6.1 Qatar Corticosteroid Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Qatar Corticosteroid Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Qatar Corticosteroid Market Revenues & Volume, By Glucocorticoids, 2021-2031F |
6.1.4 Qatar Corticosteroid Market Revenues & Volume, By Mineralocorticoids, 2021-2031F |
6.2 Qatar Corticosteroid Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Qatar Corticosteroid Market Revenues & Volume, By Topical Steroids, 2021-2031F |
6.2.3 Qatar Corticosteroid Market Revenues & Volume, By Inhaled Steroids, 2021-2031F |
6.2.4 Qatar Corticosteroid Market Revenues & Volume, By Oral Forms, 2021-2031F |
6.2.5 Qatar Corticosteroid Market Revenues & Volume, By Systemic Forms, 2021-2031F |
6.2.6 Qatar Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
6.3 Qatar Corticosteroid Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Qatar Corticosteroid Market Revenues & Volume, By Rheumatology Indications, 2021-2031F |
6.3.3 Qatar Corticosteroid Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.3.4 Qatar Corticosteroid Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.3.5 Qatar Corticosteroid Market Revenues & Volume, By Gastroenterology, 2021-2031F |
6.3.6 Qatar Corticosteroid Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.3.7 Qatar Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
7 Qatar Corticosteroid Market Import-Export Trade Statistics |
7.1 Qatar Corticosteroid Market Export to Major Countries |
7.2 Qatar Corticosteroid Market Imports from Major Countries |
8 Qatar Corticosteroid Market Key Performance Indicators |
8.1 Number of prescriptions for corticosteroids in Qatar |
8.2 Patient adherence rate to corticosteroid treatment |
8.3 Number of healthcare professionals trained in prescribing corticosteroids |
8.4 Rate of hospital admissions for conditions treated with corticosteroids |
8.5 Level of patient satisfaction with corticosteroid therapy |
9 Qatar Corticosteroid Market - Opportunity Assessment |
9.1 Qatar Corticosteroid Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Qatar Corticosteroid Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Qatar Corticosteroid Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Qatar Corticosteroid Market - Competitive Landscape |
10.1 Qatar Corticosteroid Market Revenue Share, By Companies, 2024 |
10.2 Qatar Corticosteroid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here